Basic Information
Precede Biosciences Breaks Down Barriers in Precision Medicine by Redefining What Can Be Learned from a Simple Blood Draw. By understanding the fundamental biology driving disease at any given moment, researchers and clinicians can better target drugs to the right patients in both drug development and clinical practice. Precede aims to improve the success rate of drug development and be part of building a future where every patient has access to rapid, minimally invasive diagnostics and treatments tailored to the biology of their disease.
Precede Biosciences
Boston,Massachusetts,United States of America
15~50 people
January 01, 2005
INFO@PRECEDE.BIO

